Cargando…
Identification of SOX2 as a novel glioma-associated antigen and potential target for T cell-based immunotherapy
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2359969/ http://dx.doi.org/10.1038/sj.bjc.6603802 |
_version_ | 1782152931697491968 |
---|---|
author | Schmitz, M Temme, A Senner, V Ebner, R Schwind, S Stevanovic, S Wehner, R Schackert, G Schackert, H K Fussel, M Bachmann, M Rieber, E P Weigle, B |
author_facet | Schmitz, M Temme, A Senner, V Ebner, R Schwind, S Stevanovic, S Wehner, R Schackert, G Schackert, H K Fussel, M Bachmann, M Rieber, E P Weigle, B |
author_sort | Schmitz, M |
collection | PubMed |
description | |
format | Text |
id | pubmed-2359969 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2007 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-23599692009-09-10 Identification of SOX2 as a novel glioma-associated antigen and potential target for T cell-based immunotherapy Schmitz, M Temme, A Senner, V Ebner, R Schwind, S Stevanovic, S Wehner, R Schackert, G Schackert, H K Fussel, M Bachmann, M Rieber, E P Weigle, B Br J Cancer Corrigendum Nature Publishing Group 2007-06-18 2007-06-12 /pmc/articles/PMC2359969/ http://dx.doi.org/10.1038/sj.bjc.6603802 Text en Copyright © 2007 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Corrigendum Schmitz, M Temme, A Senner, V Ebner, R Schwind, S Stevanovic, S Wehner, R Schackert, G Schackert, H K Fussel, M Bachmann, M Rieber, E P Weigle, B Identification of SOX2 as a novel glioma-associated antigen and potential target for T cell-based immunotherapy |
title | Identification of SOX2 as a novel glioma-associated antigen and potential target for T cell-based immunotherapy |
title_full | Identification of SOX2 as a novel glioma-associated antigen and potential target for T cell-based immunotherapy |
title_fullStr | Identification of SOX2 as a novel glioma-associated antigen and potential target for T cell-based immunotherapy |
title_full_unstemmed | Identification of SOX2 as a novel glioma-associated antigen and potential target for T cell-based immunotherapy |
title_short | Identification of SOX2 as a novel glioma-associated antigen and potential target for T cell-based immunotherapy |
title_sort | identification of sox2 as a novel glioma-associated antigen and potential target for t cell-based immunotherapy |
topic | Corrigendum |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2359969/ http://dx.doi.org/10.1038/sj.bjc.6603802 |
work_keys_str_mv | AT schmitzm identificationofsox2asanovelgliomaassociatedantigenandpotentialtargetfortcellbasedimmunotherapy AT temmea identificationofsox2asanovelgliomaassociatedantigenandpotentialtargetfortcellbasedimmunotherapy AT sennerv identificationofsox2asanovelgliomaassociatedantigenandpotentialtargetfortcellbasedimmunotherapy AT ebnerr identificationofsox2asanovelgliomaassociatedantigenandpotentialtargetfortcellbasedimmunotherapy AT schwinds identificationofsox2asanovelgliomaassociatedantigenandpotentialtargetfortcellbasedimmunotherapy AT stevanovics identificationofsox2asanovelgliomaassociatedantigenandpotentialtargetfortcellbasedimmunotherapy AT wehnerr identificationofsox2asanovelgliomaassociatedantigenandpotentialtargetfortcellbasedimmunotherapy AT schackertg identificationofsox2asanovelgliomaassociatedantigenandpotentialtargetfortcellbasedimmunotherapy AT schackerthk identificationofsox2asanovelgliomaassociatedantigenandpotentialtargetfortcellbasedimmunotherapy AT fusselm identificationofsox2asanovelgliomaassociatedantigenandpotentialtargetfortcellbasedimmunotherapy AT bachmannm identificationofsox2asanovelgliomaassociatedantigenandpotentialtargetfortcellbasedimmunotherapy AT rieberep identificationofsox2asanovelgliomaassociatedantigenandpotentialtargetfortcellbasedimmunotherapy AT weigleb identificationofsox2asanovelgliomaassociatedantigenandpotentialtargetfortcellbasedimmunotherapy |